Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma

Pfannenberg, Christina; Aschoff, Philip; Schanz, Sandra; Eschmann, Susanne Martina; Plathow, Christian; Eigentler, Thomas; Garbe, Claus; Brechtel, Klaus; Vonthein, Reinhard; Bares, Roland; Claussen, Claus D.; Schlemmer, Heinz Peter

doi:10.1016/j.ejca.2006.11.014

Cited by 182 publications

(122 citation statements)

References 27 publications

Supporting

Mentioning

101

Contrasting

Unclassified

Order By: Relevance

“…According to comparative studies on the detection of extracerebral metastases in melanoma patients between PET/CT versus whole-body MRI and whole-body MRI versus whole-body CT, PET/CT is superior to whole-body MRI und whole-body MRI is superior to whole-body CT [302]. This holds true for specialized centers.…”

Section: Level Of Evidence 1amentioning

confidence: 87%

“…In the diagnosis of osseous metastases, MRI has shown the highest sensitivity and specificity, albeit there is no data directly comparing MRI to CT in this type of metastasis [302]. PET/CT has displayed similar diagnostic accuracy with respect to bone metastases.…”

Section: Ct/mrimentioning

confidence: 96%

“…According to comparative studies on the detection of extracerebral metastases in melanoma patients between PET/CT versus whole-body MRI [302] and whole-body MRI versus whole-body CT [303], PET/CT is superior to whole-body MRI und whole-body MRI is superior to whole-body CT. Regarding the practical implementation of cross-sectional imaging, the practical and economic availability of the respective imaging method has to be taken into account.…”

Section: Level Of Evidence 1amentioning

confidence: 99%

See 2 more Smart Citations

Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

Pflugfelder

Kochs

Blum

et al. 2013

J Deutsche Derma Gesell

Self Cite

181

148

View full text Add to dashboard Cite

Section: Level Of Evidence 1amentioning

confidence: 87%

Section: Ct/mrimentioning

confidence: 96%

Section: Level Of Evidence 1amentioning

confidence: 99%

See 1 more Smart Citation

Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

Pflugfelder

Kochs

Blum

et al. 2013

J Deutsche Derma Gesell

Self Cite

181

148

View full text Add to dashboard Cite

“…Certain studies have compared full-body PET/CT and MR scans in the assessment of distant metastases [43][44][45][46][47]. Results are varied for anatomically different regions; the PET/CT scan is more appropriate for evaluating metastases to the lungs, while MR for lesions in the liver, bones, bone marrow and brain.…”

Section: Reviewmentioning

confidence: 99%

PET/MR — a rapidly growing technique of imaging in oncology and neurology

Sałyga

Guzikowska-Ruszkowska²,

Czepczyński

et al. 2016

Nucl. Med. Rev.

View full text Add to dashboard Cite

show abstract

“…In our study, subcutaneous and muscle metastases rate was found to be 2.05% and 0.68% respectively. Majority of available data on subcutaneous and muscular metastases in colorectal cancer are based on standard imaging techniques In a study by Pfannenberg et al (5), PET/CT imaging was shown to be more sensitive in identifying soft tissue metastases compared with magnetic resonance imaging. Therefore, soft tissue metastasis can be overlooked in patients with colorectal cancer followed with standard imaging methods.…”

mentioning

confidence: 99%

Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT

Karyağar

Kesici²,

Keçe³

et al. 2015

Turk J Gastroenterol

View full text Add to dashboard Cite

Colorectal cancer is one of the most frequently observed cancer (1). Distant metastases of colorectal cancer occur in the liver and lungs. On the other hand, subcutaneous metastases of colorectal cancer are rarely observed (2). Sufficient data showing muscular and subcutaneous metastasis rates in colorectal cancer detected with Fluorodeoxyglucose Positron Emission Tomography / Computed Tomography (PET/CT) are not available in the literature.The purpose of this study was to analyse subcutaneous and muscular metastasis rates detected using F-18 FDG PET/CT in patients with colorectal cancer. Retrospective analysis of data of 292 patients with colorectal cancer who had undergone F-18 FDG PET/ CT scanning during staging and follow-up phases from July 2009 to October 2012 were included in this study. Patients diagnosed with subcutaneous and muscular metastases were evaluated on the basis of their age, gender, localization of primary tumour , stage of disease at diagnosis, data detected using classical imaging methods during follow-up, time till F-18 FDG PET/CT imaging, localization and size of subcutaneous and muscular metastases detected with F-18 FDG PET/CT, additional metastatic foci, and any surgical procedures that the patient had undergone . After evaluating F-18 FDG PET/CT imaging results of 292 patients with colorectal cancer, subcutaneous and muscular metastasis was detected in eight patients (2.73%). Metastases was detected during the staging phase in one patient and during the follow-up phase in all other patients. The average age of patients diagnosed with metastases was 67.86 years (aged between 35-88 years). Five of these patients were male (62.5%) and three were female (37.5%). Primary tumor of six patients (75%) was localized in the colon and of two patients (25%) was localized in the rectum.In the retrospective analysis performed by Lookingbill et al. (3), cutaneous metastasis was detected in 4.4% of 413 patients with colorectal cancer whereas, cutaneous and subcutaneous metastases was detected in only three patients of (1%) 2538 patient with colorectal cancer followed in the center of Tan et al. (4). In our study, subcutaneous and muscle metastases rate was found to be 2.05% and 0.68% respectively. Majority of available data on subcutaneous and muscular metastases in colorectal cancer are based on standard imaging techniques In a study by Pfannenberg et al. (5), PET/CT imaging was shown to be more sensitive in identifying soft tissue metastases compared with magnetic resonance imaging. Therefore, soft tissue metastasis can be overlooked in patients with colorectal cancer followed with standard imaging methods. To the best of our knowledge cutaneous and muscular metastases rates of colorectal cancer using F-18 FDG PET/CT imaging are not reported in literature. In conclusion, we propose that F-18 FDG PET/CT imaging is an effective method in the detection of subcutaneous and muscular metastases of colorectal cancer. Peer-review: Externally peer-reviewed.Author contributions: Concept -S.K., U.K.; Design ...

show abstract

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma

Cited by 182 publications

References 27 publications

Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

PET/MR — a rapidly growing technique of imaging in oncology and neurology

Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT

Contact Info

Product

Resources

About